Elixinol was required to detail its funding position to the ASX after its September quarter filing […]
Finance Roundup: Elixinol defends cash position; Aurora posts record quarter with Australian boost; Avecho secures funding and stays on trial schedule; Cann Group wins NAB deadline extension; InhaleRx keeps spending tight
The Cannabis Observer
·
FOUNDING MEMBERS
First 100 readers lock in 50% off for life
Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.
- Weekday briefings on regulation, access schemes, and the companies shaping the market
- Full archive and weekly deep-dives once premium goes live
- 50% off the launch price, locked in for as long as your subscription stays active
Join 87 readers already on the waitlist
Related Articles
